Microsurgery versus stereotactic radiation for small vestibular schwannomas: A meta-analysis of patients with more than 5 years' follow-up

Otology and Neurotology

Volumn 33, Issue 9, 2012, Pages 1611-1620

  Maniakas, Anastasios ^a   Saliba, Issam ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Acoustic neuroma; CyberKnife; Gamma Knife; Microsurgery; Radiotherapy; Stereotactic Radiosurgery; Vestibular schwannoma

Indexed keywords

ADULT; COMPARATIVE STUDY; CRANIAL NERVE TUMOR; EAR SURGERY; FACIAL NERVE DISEASE; FOLLOW UP; HEARING IMPAIRMENT; HEARING TEST; HUMAN; META ANALYSIS; METHODOLOGY; MICROSURGERY; NEUROMA; POSTOPERATIVE COMPLICATION; RADIOSURGERY; REVIEW; TREATMENT OUTCOME; TRIGEMINUS NEURALGIA;

ADULT; CRANIAL NERVE NEOPLASMS; FACIAL NERVE DISEASES; FOLLOW-UP STUDIES; HEARING LOSS; HEARING TESTS; HUMANS; MICROSURGERY; NEUROMA, ACOUSTIC; OTOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RADIOSURGERY; TREATMENT OUTCOME; TRIGEMINAL NEURALGIA;

EID: 84870377067     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e31826dbd02     Document Type: Article

References (100)

1. Ahn MS, Jackler RK, Lustig LR. The early history of the neurofibromatosis. Evolution of the concept of neurofibromatosis type 2. Arch Otolaryngol Head Neck Surg 1996;122:1240-9. (Pubitemid 126752109)
2. Ballance AC. Some Points in the Surgery of the Brain and its Membranes. London, UK: MacMillan Publishing Co, 1907.
3. Stangerup S-E, Caye-Thomasen P, Tos M, et al. The natural history of vestibular schwannoma. Otol Neurotol 2006;27:547-52.
4. Propp JM, McCarthy BJ, Davis FG, et al. Descriptive epidemiology of vestibular schwannomas. Neuro Oncol 2006;8:1-11. (Pubitemid 43158221)
5. Tos M, Stangerup S-E, Caye-Thomasen P, et al. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 2004;130:216-20. (Pubitemid 38182550)
6. Consensus Development Panel. National Institutes of Health consensus development conference statement on acoustic neuroma. Arch Neurol 1994;51:201-7.
7. Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg 1980;88:555-9. (Pubitemid 10024508)
8. Anderson TD, Loevner LA, Bigelow DC, et al. Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging. Otolaryngol Head Neck Surg 2000;122:643-6. (Pubitemid 30333838)
9. van de Langenberg R, Hanssens PEJ, van Overbeeke JJ, et al. Management of large vestibular schwannoma. Part I. Planned subtotal resection followed by gamma knife surgery: radiological and clinical aspects. J Neurosurg 2011;115:875-84.
10. Yang SY, Kim DG, Chung HT, et al. Evaluation of tumour response after gamma knife radiosurgery for residual vestibular schwannomas based on MRI morphological features. J Neurol Neurosurg Psychiatr 2008;79:431-6. (Pubitemid 351441501)
11. Fuentes S, Arkha Y, Pech-Gourg G, et al. Management of large vestibular schwannomas by combined surgical resection and gamma knife radiosurgery. Prog Neurol Surg 2008;21:79-82.
12. Park C-K, Jung H-W, Kim JE, et al. Therapeutic strategy for large vestibular schwannomas. J Neurooncol 2006;77:167-71. (Pubitemid 44419751)
13. Iwai Y, Yamanaka K, Ishiguro T. Surgery combined with radiosurgery of large acoustic neuromas. Surg Neurol 2003;59:283-9; discussion 9-91. (Pubitemid 36555624)
14. House WF. Surgical exposure of the internal auditory canal and its contents through the middle, cranial fossa. Laryngoscope 1961;71: 1363-85.
15. House WF. Transtemporal bone microsurgical removal of acoustic neuromas. Report of cases. Arch Otolaryngol 1964;80:617-67.
16. House WF. Acoustic neuroma. Case summaries. Arch Otolaryngol 1968;88:586-91.
17. Hitselberger WE, Pulec JL. Trigeminal nerve (posterior root) retrolabyrinthine selective section. Operative procedure for intractable pain. Arch Otolaryngol 1972;96:412-5.
18. Zini C, Mazzoni A, Gandolfi A, et al. Retrolabyrinthine versus middle fossa vestibular neurectomy. Am J Otol 1988;9:448-50.
19. Belal A Jr. Retrolabyrinthine surgery: anatomy and pathology. Am J Otol 1986;7:29-33. (Pubitemid 16188443)
20. Brackmann DE, Hitselberger WE. Retrolabyrinthine approach: technique and newer indications. Laryngoscope 1978;88:286-97.
21. Martin C, Pradres JM, Loubeyre A, et al. [Widened retrolabyrinthine approach. Value in the surgery of acoustic neuroma with attempt of hearing preservation]. Rev Laryngol Otol Rhinol (Bord) 1995;116:119-22.
22. Darrouzet V, Tessier B, Guerin J, et al. [Enlarged retro-labyrinthic approach: application to surgery of acoustic neurinoma. Apropos of 55 cases]. Ann Otolaryngol Chir Cervicofac 1996;113:307-19.
23. Bento RF, De Brito RV, Sanchez TG, et al. The transmastoid retrolabyrinthine approach in vestibular schwannoma surgery. Otolaryngol Head Neck Surg 2002;127:437-41. (Pubitemid 36547020)
24. Prades JM, Martin C, Chelikh L, et al. [''Optimized'' retrolabyrinthine approach. Contribution of endoscopy of the cerebellopontine angle]. Ann Otolaryngol Chir Cervicofac 1995;112: 46-51.
25. Scheich M, Ginzkey C, Harnisch W, et al. Use of flexible CO(2) laser fiber in microsurgery for vestibular schwannoma via the middle cranial fossa approach. Eur Arch Otorhinolaryngol 2011; 269:1417-23.
26. Kabil MS, Shahinian HK. A series of 112 fully endoscopic resections of vestibular schwannomas. Minim Invasive Neurosurg 2006;49:362-8. (Pubitemid 46396460)
27. Shahinian HK, Ra Y. 527 fully endoscopic resections of vestibular schwannomas. Minim Invasive Neurosurg 2011;54:61-7.
28. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951;102:316-9.
29. Iwai Y, Yamanaka K, Shiotani M, et al. Radiosurgery for acoustic neuromas: results of low-dose treatment. Neurosurgery 2003;53: 282-87; discussion 7-8.
30. Bush DA, McAllister CJ, Loredo LN, et al. Fractionated proton beam radiotherapy for acoustic neuroma. Neurosurgery 2002;50: 270-3; discussion 3-5. (Pubitemid 41672581)
31. Vernimmen FJAI, Mohamed Z, Slabbert JP, et al. Long-term results of stereotactic proton beam radiotherapy for acoustic neuromas. Radiother Oncol 2009;90:208-12.
32. Weber DC, Chan AW, Bussiere MR, et al. Proton beam radiosurgery for vestibular schwannoma: tumor control and cranial nerve toxicity. Neurosurgery 2003;53:577-86; discussion 86-8.
33. Murphy ES, Suh JH. Radiotherapy for vestibular schwannomas: a critical review. Int J Radiat Oncol Biol Phys 2011;79:985-97.
34. Maniakas A, Saliba I. Conservative Management versus stereotactic radiation for vestibular schwannomas: a meta-analysis of patients with more than 5 years' follow-up. Otol Neurotol 2012; 33:230-8.
35. Pollock BE, Driscoll CLW, Foote RL, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 2006;59:77-85; discussion 77-85.
36. Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 1988;97:55-66. (Pubitemid 18067482)
37. Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of OtolaryngologyYHead and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113:179-80.
38. Hsu P-W, Chang C-N, Lee S-T, et al. Outcomes of 75 patients over 12 years treated for acoustic neuromas with linear acceleratorbased radiosurgery. J Clin Neurosci 2010;17:556-60.
39. Bush ML, Shinn JB, Young AB, et al. Long-term hearing results in gamma knife radiosurgery for acoustic neuromas. Laryngoscope 2008;118:1019-22. (Pubitemid 351787272)
40. Hasegawa TMD, Fujitani SMD, Katsumata SMD, et al. Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 2005;57:257-65.
41. Lunsford LD, Niranjan A, Flickinger JC, et al. Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 2005;102:195-9. (Pubitemid 44783953)
42. Hirsch A, Noren G. Audiological findings after stereotactic radiosurgery in acoustic neurinomas. Acta Otolaryngol (Stockh) 1988; 106:244-51.
43. Hirsch A, Noren G, Anderson H. Audiologic findings after stereotactic radiosurgery in nine cases of acoustic neurinomas. Acta Otolaryngol (Stockh) 1979;88:155-60. (Pubitemid 10224448)
44. Niranjan A, Lunsford LD, Flickinger JC, et al. Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery. Neurosurgery 1999;45:753-62; discussion 62-5.
45. Hempel JM, Hempel E, Wowra B, et al. Functional outcome after gamma knife treatment in vestibular schwannoma. Eur Arch Otorhinolaryngol 2006;263:714-8. (Pubitemid 44060973)
46. Kumon Y, Sakaki S, Kohno K, et al. Selection of surgical approaches for small acoustic neurinomas. Surg Neurol 2000;53:52-9; discussion 9-60.
47. Cohen NL, Lewis WS, Ransohoff J. Hearing preservation in cerebellopontine angle tumor surgery: the NYU experience 1974-1991. Am J Otol 1993;14:423-33. (Pubitemid 23280376)
48. Mazzoni A, Calabrese V, Danesi G. A modified retrosigmoid approach for direct exposure of the fundus of the internal auditory canal for hearing preservation in acoustic neuroma surgery. Am J Otol 2000;21:98-109. (Pubitemid 30036504)
49. Woodson EA, Dempewolf RD, Gubbels SP, et al. Long-term hearing preservation after microsurgical excision of vestibular schwannoma. Otol Neurotol 2010;31:1144-52.
50. Friedman RA, Kesser B, Brackmann DE, et al. Long-term hearing preservation after middle fossa removal of vestibular schwannoma. Otolaryngol Head Neck Surg 2003;129:660-5. (Pubitemid 37509764)
51. Fischer G, Fischer C, Remond J. Hearing preservation in acoustic neurinoma surgery. J Neurosurg 1992;76:910-7.
52. Chee GH, Nedzelski JM, Rowed D. Acoustic neuroma surgery: the results of long-term hearing preservation. Otol Neurotol 2003;24: 672-6. (Pubitemid 36886288)
53. Colletti V, Fiorino F. Is the middle fossa approach the treatment of choice for intracanalicular vestibular schwannoma? Otolaryngol Head Neck Surg 2005;132:459-66. (Pubitemid 40326701)
54. Noudel R, Gomis P, Duntze J, et al. Hearing preservation and facial nerve function after microsurgery for intracanalicular vestibular schwannomas: comparison of middle fossa and retrosigmoid approaches. Acta Neurochir (Wien) 2009;151:935-44; discussion 44-5.
55. Irving RM, Jackler RK, Pitts LH. Hearing preservation in patients undergoing vestibular schwannoma surgery: comparison of middle fossa and retrosigmoid approaches. J Neurosurg 1998;88:840-5. (Pubitemid 28215147)
56. Kaylie DM, Horgan MJ, Delashaw JB, et al. A meta-analysis comparing outcomes of microsurgery and gamma knife radiosurgery. Laryngoscope 2000;110:1850-6.
57. Shelton C, Hitselberger WE, House WF, et al. Hearing preservation after acoustic tumor removal: long-term results. Laryngoscope 1990;100:115-9. (Pubitemid 20042657)
58. Umezu H, Aiba T. Preservation of hearing after surgery for acoustic schwannomas: correlation between cochlear nerve function and operative findings. J Neurosurg 1994;80:844-8. (Pubitemid 24129680)
59. Hecht CS, Honrubia VF, Wiet RJ, et al. Hearing preservation after acoustic neuroma resection with tumor size used as a clinical prognosticator. Laryngoscope 1997;107:1122-6. (Pubitemid 27335271)
60. Satar B, Yetiser S, Ozkaptan Y. Impact of tumor size on hearing outcome and facial function with the middle fossa approach for acoustic neuroma: a meta-analytic study. Acta Otolaryngol (Stockh) 2003;123:499-505. (Pubitemid 36609768)
61. Yang I, Sughrue ME, Han SJ, et al. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma. J Neurosurg 2010;112:851-9.
62. Battista RA. Gamma knife radiosurgery for vestibular schwannoma. Otolaryngol Clin North Am 2009;42:635-54.
63. Gormley WB, Sekhar LN, Wright DC, et al. Acoustic neuromas: results of current surgical management. Neurosurgery 1997;41: 50-8; discussion 8-60.
64. Samii M, Gerganov V, Samii A. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg 2006;105:527-35. (Pubitemid 44525879)
65. Hayhurst C, Zadeh G. Tumor pseudoprogression following radiosurgery for vestibular schwannoma. Neuro Oncol 2012;14: 87-92.
66. Pollock BE. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: treatment recommendations based on a 15 year experience. Neurosurgery 2006;58:241-8; discussion 8.
67. Rutten I, Baumert BG, Seidel L, et al. Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma. Radiother Oncol 2007;82:83-9. (Pubitemid 46110916)
68. Radu A, Pica A, Villemure JG, et al. [Indications and results of stereotactic radiosurgery with LINAC for the treatment of acoustic neuromas: preliminary results]. Ann Otolaryngol Chir Cervicofac 2007;124:110-4.
69. Kalogeridi M-A, Georgolopoulou P, Kouloulias V, et al. Longterm results of LINAC-based stereotactic radiosurgery for acoustic neuroma: the Greek experience. J Cancer Res Ther 2009;5:8-13.
70. Okunaga T, Matsuo T, Hayashi N, et al. Linear accelerator radiosurgery for vestibular schwannoma: measuring tumor volume changes on serial three-dimensional spoiled gradient-echo magnetic resonance images. J Neurosurg 2005;103:53-8. (Pubitemid 43193934)
71. Haque R, Wojtasiewicz TJ, Gigante PR, et al. Efficacy of facial nerve-sparing approach in patients with vestibular schwannomas. J Neurosurg 2011;115:917-23.
72. Falcioni M, Fois P, Taibah A, et al. Facial nerve function after vestibular schwannoma surgery. J Neurosurg 2011;115:820-6.
73. Hillman T, Chen DA, Arriaga MA, et al. Facial nerve function and hearing preservation acoustic tumor surgery: does the approach matter? Otolaryngol Head Neck Surg 2010;142:115-9.
74. Jacob A, Robinson LL Jr, Bortman JS, et al. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center. Laryngoscope 2007;117:2087-92. (Pubitemid 351339578)
75. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;93:146-7. (Pubitemid 15064413)
76. Yamakami I, Uchino Y, Kobayashi E, et al. Conservative management, gamma-knife radiosurgery, and microsurgery for acoustic neurinomas: a systematic review of outcome and risk of three therapeutic options. Neurol Res 2003;25:682-90. (Pubitemid 37266688)
77. Yang J, Grayeli AB, Barylyak R, et al. Functional outcome of retrosigmoid approach in vestibular schwannoma surgery. Acta Otolaryngol (Stockh) 2008;128:881-6. (Pubitemid 351957653)
78. Pollock BE. Vestibular schwannoma management: an evidencebased comparison of stereotactic radiosurgery and microsurgical resection. Prog Neurol Surg 2008;21:222-7.
79. Gjuric M, Wigand ME, Wolf SR. Enlarged middle fossa vestibular schwannoma surgery: experience with 735 cases. Otol Neurotol 2001;22:223-30; discussion 30-1. (Pubitemid 32233479)
80. Yaku Y, Kanda T, Komatsuzaki A. Ultrastructural pathology of the vestibule in patients with acoustic neurinomas: secondarily operated cases after posterior fossa operation. Eur Arch Otorhinolaryngol 1990;247:93-6. (Pubitemid 20102936)
81. Chin LS,Ma L, DiBiase S. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. J Neurosurg 2001;94:899-904.
82. Murakami K, Jokura H, Kawagishi J, et al. Development of intratumoral cyst or extratumoral arachnoid cyst in intracranial schwannomas following gamma knife radiosurgery. Acta Neurochir (Wien) 2011;153:1201-9.
83. Shuto T, Inomori S, Matsunaga S, et al. Microsurgery for vestibular schwannoma after gamma knife radiosurgery. Acta Neurochir (Wien) 2008;150:229-34; discussion 34.
84. Lee DJ, Westra WH, Staecker H, et al. Clinical and histopathologic features of recurrent vestibular schwannoma (acoustic neuroma) after stereotactic radiosurgery. Otol Neurotol 2003;24:650-60; discussion 69. (Pubitemid 36886283)
85. Iwai Y, Yamanaka K, Yamagata K, et al. Surgery after radiosurgery for acoustic neuromas: surgical strategy and histological findings. Neurosurgery 2007;60:ONS75-82; discussion ONS.
86. Slattery WH 3rd. Microsurgery after radiosurgery or radiotherapy for vestibular schwannomas. Otolaryngol Clin North Am 2009;42: 707-15.
87. Niranjan A, Kondziolka D, Lunsford LD. Neoplastic transformation after radiosurgery or radiotherapy: risk and realities. Otolaryngol Clin North Am 2009;42:717-29.
88. Akamatsu Y, Murakami K, Watanabe M, et al. Malignant peripheral nerve sheath tumor arising from benign vestibular schwannoma treated by gamma knife radiosurgery after two previous surgeries: a case report with surgical and pathological observations. World Neurosurg 2010;73:751-4.
89. Schmitt WR, Carlson ML, Giannini C, et al. Radiation-induced sarcoma in a large vestibular schwannoma following stereotactic radiosurgery: case report. Neurosurgery 2011;68:E840-6; discussion E6.
90. Markou K, Eimer S, Perret C, et al. Unique case of malignant transformation of a vestibular schwannoma after fractionated radiotherapy. Am J Otolaryngol 2012;33:168-73.
91. Balasubramaniam A, Shannon P, Hodaie M, et al. Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro-oncol 2007;9:447-53.
92. Comey CH, McLaughlin MR, Jho HD, et al. Death from a malignant cerebellopontine angle triton tumor despite stereotactic radiosurgery. Case report. J Neurosurg 1998;89:653-8. (Pubitemid 28440938)
93. Welling DB, Guida M, Goll F, et al. Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas. Hum Genet 1996;98:189-93. (Pubitemid 26237502)
94. Caye-Thomasen P, Borup R, Stangerup S-E, et al. Deregulated genes in sporadic vestibular schwannomas. Otol Neurotol 2010; 31:256-66.
95. Mautner V-F, Nguyen R, Kutta H, et al. Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. Neuro Oncol 2010;12:14-8.
96. Clark JJ, Provenzano M, Diggelmann HR, et al. The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study. Otol Neurotol 2008;29:846-53.
97. Ammoun S, Cunliffe CH, Allen JC, et al. ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma. Neuro Oncol 2010;12:834-43.
98. Bush ML, Oblinger J, Brendel V, et al. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro Oncol 2011;13:983-99.
99. Fong B, Barkhoudarian G, Pezeshkian P, et al. The molecular biology and novel treatments of vestibular schwannomas. J Neurosurg 2011;115:906-14.
100. Bassim MK, Berliner KI, Fisher LM, et al. Radiation therapy for the treatment of vestibular schwannoma: a critical evaluation of the state of the literature. Otol Neurotol 2010;31:567-73.